← Back to catalogue

3D Bond

FDA UDI

Class II (US FDA UDI)

by Augma Biomaterials, Ltd.

Identity

Trade Name
3D Bond FDA UDI
Generic Name
Synthetic bone graft FDA UDI
Device Name
A synthetic, osteoconductive, bioresorbable graft binder cement composed of Biphasic Calcium Sulfate in a granulated powder form. 3D Bond functions as a scaffold for bone regeneration in dental procedures, and is intended to fill, augment, or reconstruct bony defects in the oral and maxillofacial region. FDA UDI
Model / Reference
DD2-050 FDA UDI
Description
A synthetic, osteoconductive, bioresorbable graft binder cement composed of Biphasic Calcium Sulfate in a granulated powder form. 3D Bond functions as a scaffold for bone regeneration in dental procedures, and is intended to fill, augment, or reconstruct bony defects in the oral and maxillofacial region. FDA UDI

Identifiers

Primary DI / UDI-DI
07290014838000 FDA UDI
510(k) Number
K083858 FDA UDI
FDA Product Code
LYC FDA UDI
GMDN Term
Synthetic bone graft FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
872.3930 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

3D Bond by Augma Biomaterials, Ltd. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Cleared under the same submission

K083858 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI a9adeb38-f97b-49a3-95b7-a3a160b34a21 36 fields · synced May 30, 2026